The success of Sildenafil initially drove a boom for pharma, nevertheless recent shifts present a murky picture for those considering a stake. Generic versions are reducing profits, and persistent legal battles add https://zubairezfc096592.digitollblog.com/41115362/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-bet